Biopharma Business

Tag "Glythera"

Exclusive access to Cancer Research UK’s inhibitor payload granted to Glythera

    Exclusive access to Cancer Research UK’s inhibitor payload granted to Glythera

The antibody drug conjugate (ADC) development company, Glythera, has been granted exclusive, worldwide rights to Cancer Research UK’s novel CDK11 inhibitor programme for the development of multiple ADCs. Under the

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements